Background Venous thromboembolism (VTE) is a well-recognized complication after total-
joint replacement (TJR). Persons with hemophilia A or B are considered at low postoperative …

Haemophilia is an inherited disease that requires a different approach in order to evaluate,
monitor and treat patients. Despite the great advances in therapeutic agents that have …

Hemophilia is a congenital bleeding disorder due to a clotting factor VIII (FVIII-hemophilia) or
factor IX (FIX-hemophilia B) deficiency. The current gold standard in hemophilia treatment is …

Total hip replacement (THR) and total knee arthroplasty (TKA) carry a high risk of
postoperative venous thromboembolism (VTE); therefore, anticoagulation prophylaxis is …

Perioperative thromboprophylaxis is recommended by the guidelines to prevent
postoperative venous thromboembolism (VTE) in patients undergoing major orthopaedic …

Haemophilia is a rare genetic disorder, that results from various degrees of deficiency of
coagulation factor VIII (haemophilia A), or factor IX (haemophilia B), with an X-linked …

Background: Patients with hemophilia A and B are at risk for progressive arthropathy and
are known to have less satisfactory outcomes when undergoing orthopaedic surgery than …

This narrative review of the literature, consisting of papers found in PubMed and The
Cochrane Library published up to 31 July 2023, analyzed those that were deemed to be …

The published literature suggests that VTE is an uncommon occurrence in persons with
hemophilia with or without inhibitors who undergo orthopedic surgery. Consequently, few …

Introduction: Patients with hemophilia are at risk for developing hemophilic arthropathy and
may require orthopedic interventions at a young age. It is unclear whether the advent of …